SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

B. Riley FBR Maintains Buy on X4 Pharmaceuticals, Lowers Price Target to $15

B. Riley FBR maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and lowers the price target from $19 to $15.

Benzinga · 05/08/2020 14:12

B. Riley FBR maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and lowers the price target from $19 to $15.